Deferred Tax Assets, Net of Valuation Allowance of Perspective Therapeutics, Inc. from 30 Jun 2015 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: Perspective Therapeutics, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 30 Jun 2015 to 31 Dec 2024.
Perspective Therapeutics, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $9,004,000, a 1.5% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Perspective Therapeutics, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$9,004,000	+$132,000	+1.5%	31 Dec 2024	10-K/A	28 Mar 2025	2024	FY
Q4 2023	$8,872,000	+$8,861,000	+80555%	31 Dec 2023	10-K/A	28 Mar 2025	2024	FY
Q4 2022	$11,000			31 Dec 2022	10-KT	01 May 2023	2023	Q1
Q2 2022	$0	$0		30 Jun 2022	10-KT	01 May 2023	2023	Q1
Q2 2021	$0			30 Jun 2021	10-KT	01 May 2023	2023	Q1
Q2 2017	$0	$0		30 Jun 2017	10-K	28 Sep 2017	2017	FY
Q2 2016	$0	$0		30 Jun 2016	10-K	28 Sep 2017	2017	FY
Q2 2015	$0			30 Jun 2015	10-K	09 Sep 2016	2016	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.